BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study

被引：29
|
作者：
Frank, Bernd [1 ]
Hemminki, Kari
Meindl, Alfons
Wappenschmidt, Barbara
Sutter, Christian
Kiechle, Marion
Bugert, Peter
Schmutzler, Rita K.
Bartram, Claus R.
Burwinkel, Barbara
机构：
[1] DKFZ, Helmholtz Univ Grp Mol Epidemiol, German Canc Res Ctr, Heidelberg, Germany
[2] DKFZ, Div Mol Genet Epidemiol, German Canc Res Ctr, Heidelberg, Germany
[3] Karolinska Inst, Ctr Family Med, Huddinge, Sweden
[4] Tech Univ Munich, Dept Obstet & Gynaecol, Klinikum Rechts Isar, D-8000 Munich, Germany
[5] Univ Cologne, Div Mol Gynaecooncol, Dept Obstet & Gynaecol, Ctr Clin, Cologne, Germany
[6] Univ Hosp Cologne, CMMC, Cologne, Germany
[7] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany
[8] Univ Heidelberg, Fac Clin Med, Inst Transfus Med & Immunol, Red Cross Blood Serv Baden Wurttemberg Hessia, Mannheim, Germany
来源：
BMC CANCER | 2007年 / 7卷 / 1期
关键词：
D O I：
10.1186/1471-2407-7-83
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Inactivating and truncating mutations of the nuclear BRCA1-interacting protein 1 (BRIP1) have been shown to be the major cause of Fanconi anaemia and, due to subsequent alterations of BRCA1 function, predispose to breast cancer ( BC). Methods: We investigated the effect of BRIP1 - 64G > A and Pro919Ser on familial BC risk by means of TaqMan allelic discrimination, analysing BRCA1/BRCA2 mutation-negative index patients of 571 German BC families and 712 control individuals. Results: No significant differences in genotype frequencies between BC cases and controls for BRIP1 - 64G > A and Pro919Ser were observed. Conclusion: We found no effect of the putatively functional BRIP1 variants - 64G > A and Pro919Ser on the risk of familial BC.
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [41] Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families
    Solyom, Szilvia
    Pylkas, Katri
    Winqvist, Robert
    FAMILIAL CANCER, 2010, 9 (04) : 537 - 540
  • [42] BRIP1-A risk gene for breast cancer?
    Weber-Lassalle, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 3 - 3
  • [43] Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families
    Szilvia Solyom
    Katri Pylkäs
    Robert Winqvist
    Familial Cancer, 2010, 9 : 537 - 540
  • [44] Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy
    Valentina Silvestri
    Piera Rizzolo
    Mario Falchetti
    Ines Zanna
    Giovanna Masala
    Simonetta Bianchi
    Domenico Palli
    Laura Ottini
    Breast Cancer Research and Treatment, 2011, 126 : 539 - 543
  • [45] Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy
    Silvestri, Valentina
    Rizzolo, Piera
    Falchetti, Mario
    Zanna, Ines
    Masala, Giovanna
    Bianchi, Simonetta
    Palli, Domenico
    Ottini, Laura
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (02) : 539 - 543
  • [46] Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations
    Badve, Shivani B.
    Kim, Emily
    Sibia, Udai S.
    Borrego, Orestes T.
    Vara, Stephen
    Damron, Alexander
    Riker, Adam I.
    OCHSNER JOURNAL, 2024, 24 (02): : 157 - 161
  • [47] BRIP1/FANCJ Mutation Analysis in a Family with History of Male and Female Breast Cancer in India
    Venkateshwari, Ananthapur
    Clark, David Wayne
    Nallari, Pratibha
    Vinod, Cingeetham
    Kumarasamy, Thangaraj
    Reddy, Goverdhan
    Jyothy, Akka
    Kumar, Malladi Vijay
    Ramaiyer, Raghuraman
    Palle, Komaraiah
    JOURNAL OF BREAST CANCER, 2017, 20 (01) : 104 - 107
  • [48] MUTATION ANALYSIS FOR BRIP1 IN KOREAN PATIENTS WITH BRCA1/2 MUTATIONS-NEGATIVE HIGH-RISK BREAST CANCER
    Kim, H.
    Cho, D.
    Choi, D. H.
    Park, W.
    Huh, S. J.
    ANNALS OF ONCOLOGY, 2014, 25
  • [49] BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes
    Gupta, Ishita
    Ouhtit, Allal
    Al-Ajmi, Adil
    Rizvi, Syed Gauhar A.
    Al-Riyami, Hamad
    Al-Riyami, Marwa
    Tamimi, Yahya
    ENDOCRINE CONNECTIONS, 2018, 7 (01): : 65 - 77
  • [50] Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer
    Velazquez, Carolina
    Esteban-Cardenosa, Eva M.
    Lastra, Enrique
    Abella, Luis E.
    de la Cruz, Virginia
    Lobaton, Carmen D.
    Duran, Mercedes
    Infante, Mar
    MOLECULAR CARCINOGENESIS, 2019, 58 (01) : 156 - 160
12345